All Articles

A pivotal partnership between WeInfuse and Trial IQ leverages AI to bring clinical trials to local infusion centers, signaling a major shift in drug development.

Tyrur Holdings' new pact with UBS isn't just another partnership. It's a masterclass in leveraging legacy power for modern agility in a volatile world.

A two-year delay for Carbios' biorecycling plant in China isn't a failure, but a harsh lesson in scaling innovation. Here's what it means for the future.

That $1 trillion pile of unused loyalty points may soon be spendable cash. A tech firm, backed by The Points Guy, is turning rewards into a currency.

A top national law firm opens in Fort Worth, but the real story is its leader—a hometown hero. This is how institutional innovation meets deep community roots.

A record-breaking loan for a Four Seasons project with no hotel signals a profound shift in how the ultra-wealthy live, and how Austin is being remade.

A landmark U.S. collaboration between Heron Power and LG aims to solve the energy crisis sparked by AI, pairing next-gen transformers with domestic batteries.

A new Sunnyvale service claims it can turn AI hardware concepts into investor-ready demos in just 21 days, attacking the notorious development bottleneck.

Signal's encryption is world-class, but it can't stop human error. A new layer of 'data-centric' security aims to protect sensitive data after it's stolen.

The refrigerated section is no longer just for basics. It's a hub for innovation where protein, convenience, and global flavors are reshaping our diets.

NexTel Medical acquires two telehealth firms for an instant $135K in monthly revenue, aiming to launch its Maxasome™ exosome therapies to 1,850 clinics.

Static PDFs and fragmented sales pitches are failing. A new class of AI-guided platforms is helping buyers build trust on their own terms. What does this mean?

With FDA clearance for its MagSense® trial, Imagion Biosystems' molecular MRI could change how we see cancer, offering a non-radioactive, high-precision future.

AM Best's negative outlook for a Pennsylvania insurer reveals a deeper crisis. A 16.5% surplus loss from weather is a harbinger for the entire sector.

As Vallarta Supermarkets expands to Merced, it reveals a masterclass in durable growth: a strategy built not on price wars, but on deep community integration.

As Rise Therapeutics advances its oral drug R-2487, it’s not just developing another pill. It’s testing a radical new idea: resetting the immune system.

EA SPORTS unveils its College Football 27 cover stars, leveraging the NIL era to fuse authenticity with a powerful subscription-driven business model.

A small startup just raised $4M to solve the biggest problem in tech: making AR glasses affordable. Their secret isn't a new gadget, but a materials science breakthrough.

A new platform, Risk Monitor, automates the tracking of permits, community sentiment, and environmental data to help developers stay ahead of project-killing risks.

Railserve's new YardGUARD™ system is more than a safety upgrade. It's a strategic move to rewire industrial rail with integrated, real-time intelligence.